| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.4 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |